The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frank, G. D.
Right arrow Articles by Parnes, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frank, G. D.
Right arrow Articles by Parnes, J. R.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
The Journal of Immunology, 1998, 160: 634-642.
Copyright © 1998 by The American Association of Immunologists

The Level of CD4 Surface Protein Influences T Cell Selection in the Thymus1

Gregory D. Frank*,{dagger} and Jane R. Parnes2,{dagger}

* Program in Immunology and {dagger} Department of Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA 94305


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
During T cell development thymocytes are subjected to positive and negative selection criteria to ensure that the mature T cell repertoire is MHC restricted, yet self tolerant at the same time. The CD4 and CD8 coreceptors are thought to play a crucial role in this developmental process. To elucidate the role of CD4 in T cell selection, we have produced a mouse strain that expresses CD4 at a reduced level. We used homologous recombination in embryonic stem cells to insert neo into the 3' untranslated region of CD4. The resulting mice have a reduction in the percentage of CD4+ cells in the thymus and a concomitant increase in CD8+ cells. In addition, breeding two individual class II-restricted TCR transgenic mice onto the CD4low (low level of CD4) mutant background affects the selection of each TCR differentially. In one case (AND TCR transgenic), significantly fewer CD4+ cells with the transgenic TCR develop on the CD4low mutant background, whereas in the other (5C.C7 TCR transgenic), selection to the CD4 lineage is only slightly reduced. These data support the differential avidity model of positive and negative selection. With little or no avidity, the cell succumbs to programmed cell death, low to moderate avidity leads to positive selection, and an avidity above a certain threshold, presumably above one that would lead to autoreactivity in the periphery, results in clonal deletion. These data also support the idea that a minimum avidity threshold for selection exists and that CD4 plays a crucial role in determining this avidity.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
Mature T cells are divided into almost mutually exclusive subsets of cells that express either CD4 or CD8 (reviewed in Refs. 1 and 2) and have helper or cytotoxic function, respectively. It is during development in the thymus that T cells become MHC restricted and committed to their respective lineages. To ensure that the T cell repertoire is self tolerant yet retains the ability to recognize Ag in the context of self MHC, thymocytes are subjected to positive and negative selection. Positive selection is the process that yields T cells that have TCRs that recognize self MHC molecules (3, 4), while negative selection is the process by which potentially autoreactive thymocytes are deleted in the thymus (5, 6). Because rearrangement of the TCR genes is random, many T cells that are generated at the double-positive (DP;3 CD4+CD8+) stage have TCR with little or no affinity for MHC or never successfully rearrange their TCR genes. These cells are subjected to programmed cell death (PCD). This fate, which has also been termed death by neglect, is the default state that ensues without a signal to rescue the developing T cell, i.e., without a signal for positive selection. The term PCD is used here to refer only to those cells that fail positive selection and not those that die by negative selection. The avidity of the interaction between developing T cells and thymic stromal cells determines the fate of that cell. While the affinity of the TCR for its ligand is probably the single most important variable determining avidity, it is not the only factor. Avidity includes the influence of other proteins, such as coreceptors (2) and adhesion molecules, on the stability of the TCR/MHC complexes as well as the density of TCR and its cognate ligand (7). Thus, an emerging T cell with a high avidity interaction would lead to negative selection (also known as clonal deletion), one of moderate avidity would lead to positive selection, and one of low or no avidity would lead to PCD or death by neglect. This model, now widely known as the differential avidity model for T cell selection (8), is supported by recent in vivo (9, 10) and in vitro (11, 12, 13) findings.

CD4 is an adhesion molecule that interacts with MHC class II and, by binding to a nonpolymorphic region of class II (14, 15), can also engage in coreceptor signaling (16, 17). Coreceptor signaling is the synergy that results (18) from CD4 and TCR binding the same MHC ligand and the concomitant juxtaposition of Lck with the CD3 signaling complex. Lck is a nonreceptor protein tyrosine kinase that binds to the cytoplasmic domain of CD4 (19). CD4 plays a crucial role in the development of class II-restricted Th cells in great part due to its ability to boost the avidity of the interaction between thymocyte and stromal cell during selection. Neonatal injection of anti-CD4 mAb blocked the development of CD4 single positive (SP) thymocytes (20) as it did in fetuses of pregnant mice treated until birth (21). CD4 can also function independently of its association with Lck, albeit less efficiently than CD4 with Lck. This was revealed in experiments with mice expressing a CD4 transgene (tg) that lacks the cytoplasmic tail, on a CD4 knockout (CD40) background (22). Strikingly, there was a direct correlation between the proportion of CD4-lineage cells and the level of cell surface expression of the tailless CD4 molecule. The greater the overexpression of the tg, the more CD4 T cells. Thus, a tailless CD4 expressed at physiologic levels results in a reduction in CD4 T cells, but this inability to coreceptor signal can be compensated for by gross overexpression. Interestingly, mice that lack CD4 altogether have a small population of double-negative (DN), i.e., CD8- peripheral T cells with helper function (23, 24). Interpreted in the context of the differential avidity model, coreceptors increase the avidity of T cells engaged in selection, and their associated protein tyrosine kinases actively take part in the TCR signaling pathway. CD4 is not essential for the development of class II-restricted Th cells, but greatly enhances this process.

To study the role of CD4 in positive and negative selection, we set out to replace the exons that encode the transmembrane and cytoplasmic domains of CD4 with those of CD8. To do this, we used homologous recombination (25, 26) in embryonic stem (ES) cells. However, instead of the intended integration, we inserted the neomycin resistance gene (neo) into the 3' untranslated region (UTR) of CD4. The resulting mice (CD4low), after blastocyst injection and breeding for homozygosity of the mutant CD4 gene, have a reduced level of CD4 protein on the surface of their T cells throughout development. In the CD4low mutant mice we found a decrease in the proportion of CD4 cells in the thymus with a concomitant increase in CD8 cells and a significant skewing of the TCR repertoire with respect to several V region gene products. To study the fate of individual TCRs with reduced CD4, we bred two different class II-restricted TCR tg onto the CD4low mutant background. In these TCR tg/CD4low mutant mice we saw a reduction in the percentage of T cells being selected into the CD4 compartment. Our data are consistent with, and interpretable in the context of, the differential avidity model of T cell selection.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
Construction of targeting vector

The 10.5-kb 3' EcoRI fragment of mouse genomic CD4 (27) containing exons 5 to 10 in the pBluescript vector (Stratagene, La Jolla, CA) was used to generate the targeting vector. The 3.5-kb BglII fragment was excised and inserted into a modified Bluescript vector that contained no polylinker and only a BglII site for cloning. The following manipulations were performed on this BglII cassette. The SacI-PvuII fragment (exons 8 and 9 and part of exon 10, representing the region coding for the transmembrane and cytoplasmic domains) was removed, and the SacI-BglII/blunt fragment of genomic mouse CD8 (representing exons 3 and 4 and part of exon 5) was cloned in its place. The SphI site in the 3' UTR (exon 10) was converted into an XhoI site with linkers. The 1.3-kb EcoRI-BamHI fragment of neo under control of the PGK promoter (28) was cloned into this site with XhoI linkers. The BglII cassette was then inserted back into the BglII site of the 10.5-kb EcoRI fragment of genomic CD4. The ClaI-NotI/blunt (polylinker sites) fragment of this construct was cloned into the ClaI-HindIII/blunt site of pHSV-106 (TV5tk; Fig. 1GoB). Twenty micrograms of this final targeting vector was linearized with ClaI for transfection. All DNA manipulations were performed as previously described (29) with enzymes from New England BioLabs (Beverly, MA).



View larger version (13K):
[in this window]
[in a new window]
  		FIGURE 1. Schematic diagram depicting the targeting scheme. A, The mouse CD4 locus. B, The targeting vector used for homologous recombination. C, Consequence of homologous integration: neo insertion into the 3' UTR of CD4. Black boxes indicate CD4 exons; gray boxes indicate transmembrane and cytoplasmic exons of mouse CD8{alpha}; stippled box indicates the neo gene; checkered box indicates HSV-tk. The intended integration sites are marked with a black X, the actual 5' integration site is marked with a gray X. R1, EcoRI; B, BamHI; S, SacI; Pv, PvuII; Sp, SphI; Bg/bl, blunted BglII; X, XhoI.

 
Generation of CD4low mutant mice

The linearized targeting vector (20 µg) was electroporated at 275 V and 200 µF, with a BTX 300 electroporator (BTX, Inc., San Diego, CA) into ES-D3 C-12, a subclone of D3 ES cells (30). Cells were subjected to G418 (Life Technologies, Gaithersburg, MD; 400 µg/ml) and 1-[2-deoxy-2-fluoro-ß-D-arabinofuranosyl]-5-iodouracil (fiayluridine (FIAU)) for 10 days. Single-colony wells were expanded for DNA isolation and Southern blot analysis. Chimeric mice were generated by microinjection of the targeted ES cell into the blastocoel cavity of 3.5-day-old C57BL/6 blastocysts (31). Chimeric males were mated with C57BL/6 females, and agouti-colored offspring were screened for germ-line transmission by Southern blot analysis.

Generation of inbred strains

Heterozygous offspring were backcrossed onto C57BL/6 or B10.BR mice for a minimum of six generations. At each generation, tail DNA was isolated, and Southern blot analysis was performed to track the mutant gene. For experimental mice, heterozygous mice were intercrossed to generate wild-type, mutant, and heterozygous offspring. Wild-type and mutant offspring from the same litter (littermates) were used for experiments. For double-mutant mice, CD4low homozygous mutant mice (CD4low mutant) were crossed to ß2m-deficient mice (ß2m0). Double-heterozygous littermates were intercrossed to obtain CD4low het/ß2m0 mice, which were then intercrossed to get CD4low mutant/ß2m0 and CD4 WT/ß2m0 littermates for experimentation. The 5C.C7 TCR tg mice, a gift from Dr. Mark M. Davis (Stanford University School of Medicine), were maintained on the B10.BR background. The AND TCR tg mice, a gift from Dr. Stephen M. Hedrick (University of California, San Diego, CA) (32) were maintained on the C57BL/6 background. For experiments with tg/CD4low mutant mice, tg+/CD4low het mice were intercrossed with tg-/CD4low het mice to obtain tg+/CD4 WT, tg+/CD4low mutant, and tg-/CD4 WT littermates. All mice used for breeding were obtained from The Jackson Laboratory (Bar Harbor, ME). TCR tg mice were identified by cell surface staining with fluorochrome-labeled Abs and flow cytometry, while the CD4 gene was tracked by Southern blotting of tail DNA.

Abs and flow cytometry

Anti-CD8{alpha} (clone 53.67.2, American Type Culture Collection, Rockville, MD) and anti-Vß8.1, 8.2, 8.3 (clone F23.1) were purified from culture supernatant by protein G-Sepharose (Pharmacia, Uppsala, Sweden) chromatography and conjugated to FITC (Molecular Probes, Eugene, OR) or biotin (Pierce Chemical Co., Rockford, IL). The following Ab were purchased from PharMingen (San Diego, CA): PE-conjugated anti-CD4 (clone RM4–5), biotinylated anti-CD5 (clone 53–7.3), biotinylated anti-CD3{epsilon} (clone 145–2C11), biotinylated anti-CD69 (clone H1.2F3), biotinylated anti-CD24 (HSA; clone M1/69), FITC-conjugated anti-Vß3 (clone KJ25), FITC-conjugated anti-Vß8.1, 8.2 (clone MR5–2), biotinylated anti-V{alpha}2 (clone B20.1), and biotinylated anti-V{alpha}11 (clone RR8–1). The following Ab were used as culture supernatant: anti-V{alpha}3.2 (clone RR3–16; a gift from Dr. Osami Kanagawa, Washington University, St. Louis, MO) detected with FITC-conjugated mouse anti-rat Fc (Jackson ImmunoResearch Laboratories, West Grove, PA) and anti-Vß14 (clone 14.2; a gift from Dr. David Raulet, University of California, Berkeley, CA) detected with FITC-conjugated goat anti-rat IgM (Jackson ImmunoResearch Laboratories). Anti-V{alpha}3, a rabbit antiserum, was a gift from Drs. Bee-Cheng Sim and Nicholas R. J. Gascoigne (The Scripps Research Institute, La Jolla, CA) and was detected with FITC-conjugated donkey anti-rabbit (Jackson ImmunoResearch Laboratories). Ab were used at predetermined optimal concentrations. Spleens and thymi were prepared for flow cytometry by making a single-cell suspension with the sintered ends of two glass slides. One million cells were stained and washed in PBS/2% FCS/0.05% azide. Three-color flow cytometry was performed with a FACScan cytometer (Becton Dickinson, San Jose, CA), and data were analyzed using FACS-DESK software and displayed as density plots or as 5% probability contour plots. FITC-labeled, PE-labeled, and biotinylated mAb, with PerCP (BD, San Jose, CA) secondary reagent, were used throughout. PBL from transgenic mice were isolated using Lympholyte-M (Cedarlane Laboratories Ltd., Hornby, Canada) and stained as described above.

Southern blotting

Tail biopsy was incubated with proteinase K (Life Technologies) at 56°C overnight in serum separator tubes (Vacutainer, Becton Dickinson, Franklin Lakes, NJ). The genomic DNA was extracted with phenol/chloroform, then with chloroform, in the same tubes. DNA was precipitated in microfuge tubes with sodium acetate and isopropanol, then washed with ethanol. Five micrograms of DNA was digested overnight at 37°C with BamHI (New England BioLabs, Beverly, MA). Gel electrophoresis was performed as previously described (29). Transfer to a nylon membrane, probe labeling, hybridization, washing, and detection were performed with the Genius System (Boehringer Mannheim, Indianapolis, IN) according to the manufacturer’s instructions. The probe was a 630-bp EcoRI fragment of genomic CD4 from the 3' flanking region immediately outside the targeting vector (Fig 1GoC).

Northern blotting

Total RNA was isolated from thymus using RNAzol (Tel-Test, Inc., Friendswood, TX) according to the manufacturer’s instructions. mRNA was then purified using Oligotex (Qiagen, Chatsworth, CA). Twenty micrograms of total RNA or 0.2 µg of mRNA were electrophoresed, transferred to a nylon membrane (Boehringer Mannheim), hybridized, and washed as previously described (33). The EcoRI-BamHI fragment of neo or the 414-bp SacI-KpnI (exons 2–5) fragment of the mouse CD4 cDNA was labeled with 32P by random hexamer priming and used as a hybridization probe.

Immunoprecipitation and immunoblot analysis

Thymocytes were surfaced labeled with sulfo-NHS-biotin (Pierce) (34). Total cell lysates were made by incubating cells in lysis buffer containing 1.0% Triton X-100 (Sigma) and protease inhibitors (Boehringer Mannheim) on ice for 30 min. Nuclei and cytoskeletal components were removed by microcentrifugation at maximum speed for 15 min in the cold room. Lysates were frozen at -80°C or used immediately. Immunoprecipitation with anti-CD4 (CT CD4, Caltag) or anti-CD8{alpha} (53.67.2, American Type Culture Collection, Rockville, MD) mAb preincubated with protein G-Sepharose (Pharmacia; 5 µg of mAb plus 30 µl of protein G slurry) was performed at 4°C using a rotary mixer. Lysates were precleared with nonspecific isotype-matched control Ab, preincubated with protein G-Sepharose, for 1 h at 4°C. The samples were washed five times, resuspended in loading buffer containing 1% 2-ME, and electrophoresed on a 10% SDS-polyacrylamide gel. The gels were electroblotted onto nitrocellulose (Schleicher and Schuell, Keene, NH). Western blotting was performed with peroxidase-conjugated streptavidin (Jackson ImmunoResearch Laboratories) in PBS/0.1% Tween (Sigma)/5% nonfat dry milk powder (Carnation, Los Angeles, CA) followed by ECL (Amersham, Arlington Heights, IL) and exposure to Hyperfilm (Amersham).

cDNA library construction, screening, and sequencing

Total RNA was isolated from CD4low mutant thymi as described above. mRNA was purified using the Poly(A) Quick mRNA Isolation Kit from Stratagene (La Jolla, CA). The library was constructed using the ZAP-cDNA Gigapack II Gold Cloning Kit from Stratagene and screened according to the manufacturer’s instructions using the same CD4 probe as that used for Northern analysis. Six individual clones were isolated, then sequenced in both directions using the dideoxy chain termination method. The numbering for the cDNA sequence shown is taken from the mouse CD4 cDNA sequence in GenBank (accession no. X04836).


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
Generation of CD4low mutant mice

CD4low mice were generated by standard techniques using the 129/sv embryonic cell line D3 (31). A targeting vector was constructed to introduce an expressible neo into the 3' UTR of CD4 by homologous recombination. The targeting vector is shown in Figure 1GoB. Genomic CD4 spanning intron 5 through the 3' flanking region was used to generate the targeting vector. The neo gene was inserted in the 3' UTR at the SphI site using XhoI linkers. This neo gene was driven by the PGK promoter (28) and used the poly(A) signal of the CD4 gene for expression after integration. The HSV-tk gene driven by the PGK promoter was inserted at the 3' end of the targeting vector to allow negative selection (35) against random integrants by plating on FIAU. The targeting vector was linearized with ClaI and electroporated into ES-D3 cells (30). These cells were subjected to both positive (G418) and negative (FIAU) selection. G418-resistant clones were analyzed by Southern blot (Fig. 2Go) and used for blastocyst injection. Although we originally intended to introduce exons encoding the transmembrane region and cytoplasmic domain of CD8 into the CD4 locus (Fig. 1GoB, gray exon boxes), homologous recombination occurred such that only neo was introduced. The remainder of the CD4 gene remained intact. Two clones were selected for microinjection into blastocysts and gave germ-line transmission. One line was interbred to generate homozygous mice. The mutation was backcrossed onto two different inbred mouse strains, C57BL/6 and B10.BR, for at least six generations. The mice were viable and healthy and displayed no overt abnormalities. In-depth characterization of the CD4 gene and flanking regions by Southern blot analysis was performed using a variety of restriction digests and probes (data not shown). This analysis revealed that a single copy of neo was introduced, and the sites flanking this integration were intact. Based on tail DNA analyses of hundreds of progeny generated by intercrossing heterozygous mice, the ratio of birth of wild-type (wt), heterozygous, and mutant (CD4low) mice was approximately 1:2:1.



View larger version (74K):
[in this window]
[in a new window]
  		FIGURE 2. Southern blot of tail DNA from wt, CD4low mutant (M), and heterozygous (HET) mice. The DNA was digested with BamHI and hybridized with the 650-bp EcoRI fragment of CD4, just 3' of the targeting vector (Fig. 1GoC). The marker is phage {lambda} DNA digested with HindIII; sizes are given in kilobases.

 
Result of targeting the 3' UTR

Placing neo into the 3' UTR of CD4 resulted in a lower level of CD4 surface protein on all T cells that normally express CD4. This is revealed by flow cytometric analysis in Figure 3Go. The difference is most obvious in the DP population in the thymus, where the level of CD4 in the mutant is 50% that in the wt. In the SP thymocyte population and on splenic T cells, the level of CD4 in the mutant is 80% that in the wt. Immunoprecipitation of CD4 from thymocytes (Fig. 4Go) revealed about a twofold difference in the amount of protein from mutant vs. wt cells. Whole thymocyte suspensions were surfaced labeled with biotin, and total cell lysates from equal numbers of cells were subjected to immunoprecipitation with anti-CD4 mAb and protein G-Sepharose. The immunoprecipitations were resolved by PAGE, and the biotinylated proteins were detected by ECL and x-ray film exposure. Densitometry (data not shown) revealed a twofold difference in CD4 protein from mutant vs. wt cells when corrected for immunoprecipitation of the control protein, CD8 (Fig. 4Go). To try to understand the cause of the lower level of CD4 protein in mutant cells, we performed Northern blot analysis of RNA from mutant and wt thymi (data not shown). Not so unexpectedly, we found two species of CD4 RNA in the mutant mouse. The predominant species is larger than wt CD4. Its size suggests that it represents complete read-through of the CD4 gene including neo. This conclusion is substantiated by the finding that parallel blots hybridized with a neo probe revealed the same size band (data not shown). A minor species on the CD4-hybridized blot is smaller and results from utilization of an alternate, yet inefficient, polyadenylation signal. This was verified by the isolation and sequencing of clones from a cDNA library constructed from mutant thymus RNA (data not shown). The sequence of this poly(A) signal is AATGAA. Sheets et al. (36) have shown that a motif with this sequence can direct polyadenylation, albeit to an extent far less than the canonical AATAAA.



View larger version (17K):
[in this window]
[in a new window]
  		FIGURE 3. CD4low mutant mice have reduced levels of CD4 cell surface protein. Flow cytometric analysis was used to compare the CD4 protein level in wt mice (dashed line) with that in CD4low mutant mice (solid line). Thymus and spleen from 4.5-wk-old littermates were stained with PE-conjugated anti-CD4 and FITC-conjugated anti-CD8. The level of CD4 staining is displayed as a one-dimensional density plot, with CD4 on the x-axis and relative cell number on the y-axis, for DP thymocytes, CD4 SP thymocytes, and CD4+ splenocytes (spleen). The number in each box is the level of CD4 staining of mutant cells as a percentage of that of wt cells.

 


View larger version (27K):
[in this window]
[in a new window]
  		FIGURE 4. Immunoprecipitation of CD4 reveals a twofold reduction in protein in mutant vs wt littermates. CD8 and CD4 were immunoprecipitated with 53.67.2 and CT-CD4, respectively, and protein G-Sepharose from thymocytes of wt or CD4low mutant (M) mice.

 
Reduced CD4 protein alters CD4/CD8 thymic subsets

We were interested to see what effect this reduced level of CD4 surface protein would have on the development of T cells. Two-color flow cytometry revealed an increase in the CD8 compartment and a decrease in the CD4 compartment of thymocytes stained with FITC-conjugated anti-CD8 and PE-conjugated anti-CD4 (Fig. 5GoA). The number of cells in the mutant thymus was equivalent to that in the wt thymus. The reduction in the CD4 compartment was consistent and averaged 19.1% over 12 pairs of mice tested. This reduction in CD4+ cells and increase in CD8+ cells persisted in peripheral T cells, although to a lesser extent than in thymocytes, as indicated by a similar staining of splenocytes (Fig. 5GoB). This pattern in splenocytes was also consistent over 12 pairs of mice tested (data not shown). Most notable in the thymus was a consistent increase in the CD8 compartment, which averaged 67.1% over 12 pairs of mice tested. To characterize this phenotypic change in greater depth, we performed three-color staining of thymocytes with a panel of Abs in conjunction with CD4/CD8 staining. This analysis revealed that the increase in CD8+ cells in the thymus of mutant mice is predominantly (>70%) due to cells that are CD3low/med, CD5low, CD69low, and HSAhigh (Table IGo). This phenotype is indicative of CD8+ cells in transition from DN to DP as they are immature in character. Our interpretation of these results is that CD4 mRNA has been destabilized by insertion of neo into the 3' UTR, and this has retarded the surface expression of CD4 protein during this DN to DP transition. The mutant mice have a greater percentage of DN cells, which also supports this interpretation.



View larger version (60K):
[in this window]
[in a new window]
  		FIGURE 5. CD4low mutant mice have an altered CD4/CD8 profile in both thymus and spleen. Flow cytometric analysis compared CD4low (mutant) mice with wt littermates. Thymus (A, top panels) and spleen (B, bottom panels) were isolated from 10-wk-old mice and stained with PE-conjugated anti-CD4 (y-axis) and FITC-conjugated anti-CD8 (x-axis). Data are presented as 5% probability plots. The numbers represent the percentage of cells in the corresponding quadrant.

 

View this table:
[in this window]
[in a new window]
  		Table I. The percentage of CD8+ cells in gated populations for wild-type (wt) and CD4low (mutant) littermatesa

 
To ensure that most of the increase in CD8+ cells was due to immature CD8+ transitional intermediates, we crossed the CD4 mutant gene onto the ß2m0 background. The ß2m0 mice lack MHC class I surface expression and, hence, are unable to positively select CD8 T cells. In the double-mutant mice (CD4low/ß2m0; data not shown), we saw an increase in CD8+ cells similar to that seen in the CD4low/ß2m+ mice, and as in the CD4low/ß2m+ mice, these cells were all CD69low, HSAhigh, CD5low, and CD3low/med (data not shown). Further supporting the idea that these cells are immature intermediates, they did not appear in the periphery of the double-mutant mice (data not shown).

Reduced CD4 level affects the selection of class II-restricted TCR

We hypothesized that the reduction in the CD4 SP thymocytes was due to the lower level of CD4 surface protein, and that this lower level reduced the avidity of cells engaged in positive selection and hence rendered the selection of CD4+ class II-restricted T cells less efficient than that in wt littermates. To test this, we mated the CD4low mutant mice to two different class II-restricted TCR transgenic mice. One group of mice we tested expressed the 5C.C7 TCR tg. These mice express a TCR that recognizes a peptide of pigeon cytochrome c (PCC) (88–104) in the context of I-Ek and selects almost exclusively to the CD4 lineage (32, 37). The difference in CD4+ cells in the thymus of these tg+/CD4low mutant animals compared with those in tg+/CD4 wt animals was modest (Fig. 6Go). The tg+/CD4low mutant mice had slightly fewer (12% fewer than tg+/CD4 wt; Fig. 6Go) CD4+ SP cells in the thymus. However, when the AND TCR tg was mated onto the CD4low mutant background, a much more glaring effect was seen. The AND mice express a TCR tg that recognizes the same peptide of PCC in the context of I-Ek (32, 38), but because we maintain these mice on the C57BL/6 background the TCR is positively selected by I-Ab. Positive selection can occur on I-Ek or I-Ab. This TCR is also almost exclusively selected to the CD4 lineage. As can be seen in Figure 7GoA, the tg+/CD4low mutant thymus had a 58% reduction in CD4 SP thymocytes compared with littermates expressing the tg alone (tg+/CD4 wt). In four experiments, the average reduction in CD4 SP thymocytes in the tg+/CD4low mutant compared with the tg+/CD4 wt was 52% (57, 58, 76, and 16%). In all experiments comparing tg+/CD4 wt mice with tg+/CD4low mutants using either TCR tg, the thymi in the tg+/CD4low mutant mice had more cells, moderately more in the 5C.C7 mice (21 and 30%), but considerably more in the AND mice (70, 110, 113, and 33%). The final pair of this latter group (33%) did not consist of littermates, and the mice were not age matched.



View larger version (39K):
[in this window]
[in a new window]
  		FIGURE 6. The CD4low mutant background only moderately affects the selection of cells to the CD4 compartment with the 5C.C7 TCR tg. A comparison was made of the 5C.C7 TCR tg on the wt CD4 background (Tg+/wt; left panel) and the CD4low mutant background (Tg+/Mutant; right panel) in littermates. The numbers represent the percentage of cells in the corresponding quadrant. Cells were stained and displayed as described in Figure 5Go.

 


View larger version (68K):
[in this window]
[in a new window]
  		FIGURE 7. The CD4low mutant background leads to a significant reduction in the selection of cells to the CD4 compartment with the AND TCR tg. Comparison of the AND TCR tg on the wild-type CD4 background (Tg+/wt; left panels) and the CD4low mutant background (Tg+/Mutant; right panels) in thymus (A, top panels) and spleen (B, bottom panels) of littermates. The numbers represent the percentage of cells in the corresponding quadrant. Cells were stained and displayed as described in Figure 5Go.

 
Reduced CD4 protein level alters TCR repertoire

To study how the reduced CD4 level affects the TCR repertoire in a more global fashion, three-color staining analysis of thymocytes was undertaken using Abs to CD4, CD8, and a panel of TCR V{alpha} and Vß gene products. We analyzed CD4low mutant mice that had been backcrossed a minimum of six generations onto either C57BL/6 or B10.BR. The data in Table IIGo show the statistical analysis of the percentage of cells that are CD4+CD8- and express a particular TCR V region gene product in wild-type vs mutant mice. On the C57BL/6 background, the reduced CD4 protein resulted in statistically significant reduction in four of the TCR V region gene products in the CD4 SP thymocyte population (V{alpha}2, V{alpha}3.2, Vß8, and Vß13). However, on the B10.BR background, the reduced CD4 level affected only one of the TCR V gene products in a statistically significant fashion (Vß13).


View this table:
[in this window]
[in a new window]
  		Table II. Flow cytometric analysis comparing CD4low (mutant) and wild-type (wt) littermates for usage of various TCR V{alpha} and TCR Vß gene productsa

 

   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
The targeting of neo into the 3' UTR of CD4 (Fig. 1Go) resulted in mice with a reduced level of CD4 protein (Fig. 3Go) in all cells. This level is twofold lower in the thymus of mutant mice compared with that in wt littermates (Fig. 4Go). The reduction in CD4 protein level on the cell surface influenced the proportion of CD4 and CD8 SP cells in the thymus of CD4low mutant mice (Fig. 5Go). By reducing the level of CD4 protein on the surface of developing thymocytes, we have rendered the selection of cells to the CD4 lineage less efficient by lowering the overall avidity of the interaction. The increase in the CD8 compartment in CD4low mutant mice appears to have two explanations. Most of the increase in CD8+ cells is due to cells with an immature phenotype. These cells are CD3low, CD69low, CD5low, and HSAhigh. This phenotype is characteristic of cells in transition from DN to DP (39) in certain strains of mice (40). In C57BL/6 mice, cells in transition from DN to DP are skewed toward expressing CD8 before CD4. The most likely explanation for the increase in this immature population in our CD4low mice is retarded expression of CD4 protein at the transition of DN to DP cells, presumably due to CD4 mRNA instability (41, 42). These immature CD8+ cells make up the bulk of the increase in the CD8 compartment (75%; Table IGo). The remainder of the increase (25%) is due to CD8+ cells that are transitionally mature to mature, i.e., CD3high CD5high CD69high HSAlow. Because the thymi from mutant and wt littermates are the same size (data not shown), decreasing the proportion of CD4 cells increases the proportion of CD8 cells. To verify this, we mated the CD4low mutant mice to the ß2m0 mice. In the double-mutant animals an increase in the CD8 compartment persists (data not shown). However, this increase is almost entirely (+90%) composed of CD8+ immature cells. The almost complete lack of class I surface expression ensures that very few CD8 SP cells will reach full maturity.

In normal mice the level of CD4 is higher in SP thymocytes and spleen than in DP thymocytes. Our mutant mice are no exception. Interestingly, the difference in the level of CD4 between mutant and wt is greater in DP thymocytes (where mutant is 50% of wt) than in SP thymocytes (where mutant is 80% of wt; Fig. 3Go). We believe that this reflects the process of positive selection and supports a differential avidity model and the idea that the majority of thymocytes fail positive selection (43). Most TCRs, which are generated by the random recombination of gene segments, have little or no affinity for MHC. Cells bearing these receptors die by neglect (43); they are unable to generate a signal through the TCR to rescue them from PCD. Even though we have generated mice with a reduced level of CD4, there is still a normal distribution of the level of CD4 protein on developing thymocytes. Thus, the cells passing positive selection do so with the highest level of CD4. However, this level is still lower, on the average, in the mutant thymocytes than in the wt thymocytes.

The mating of the CD4low mutant to the two individual TCR tg mice presents us with some interesting data. These experiments open a window into the affinity of the individual TCRs. TCRs that are positively selected and not negatively selected will fall into a certain window of affinity. Because we are limited in the number of tg mice we use with differing affinity TCRs, it is hard to get a feel for this window or where in this range each individual TCR lies. Several groups have expressed tg coreceptors that increase positive selection (44, 45) or tip the balance on a TCR tg from positive selection to negative selection (9, 10, 46) or vice versa (47, 48). Our system provides a similar, yet more subtle, result. In the AND tg/CD4low mutant, the positive selection of TCR tg to the CD4 lineage is significantly reduced (58%) compared with that in tg/wt littermates (Fig. 7Go). That would place the affinity of this TCR for its ligand near the lower limit, as a reduction in the CD4 level leads to failure of positive selection. The genes encoding this TCR were originally isolated from a T cell clone that recognizes the C-terminal peptide of PCC in the context of I-Ek (32). Both the AND and 5C.C7 TCRs are very similar, incorporating V{alpha}11 and Vß3 gene segments. However, they do incorporate different J{alpha} segments and have distinct junctional sequences (49). Despite this, Yelon and Berg (50) recently showed data indicating that AND and 5C.C7 were about as strongly selected as each other on I-Ek, with AND being slightly more efficient than 5C.C7. Since we bred the AND tg onto the C57BL/6 strain, the TCR is being positively selected by the I-Ab molecule because these mice do not express I-E. This positive selection is by cross-reactivity to I-Ab, since PCC-specific helper T cells are restricted by I-E and not I-A (37, 51). It seems logical, then, that the TCR is being positively selected with a lower affinity, by cross-reactivity, to I-Ab than it would if it were being selected by I-Ek, its restricting MHC. In agreement with this interpretation, Matechak et al. (52) recently found that H-2k AND TCR mice have small thymi with a reduced compartment of DP thymocytes and an increased proportion of DN thymocytes, while H-2b AND TCR mice have large thymi and mature cells predominantly in the CD4 lineage. Their interpretation is that homozygous expression of Ek induces some clonal deletion of AND TCR-expressing cells. By reducing the amount of CD4 available during positive selection, we believe that a significant portion of T cells that would have been positively selected fail to be so, supporting the idea that a minimum avidity threshold exists for positive selection. Having a TCR with some affinity for MHC (AND) may not insure escape from PCD without a minimum overall avidity. Thus, CD4 plays a critical role in determining overall avidity of cells undergoing selection and whether they can escape death by neglect. In the 5C.C7 tg/CD4low mutant, on the other hand, selection to the CD4 lineage is reduced only slightly (Fig. 6Go). We interpret these data to mean that the affinity of this TCR for its ligand (peptide plus Ek) is in the upper range of the affinity window. In agreement with these data, Yelon and Berg (50) found that 5C.C7 thymocytes can mature with maximum efficiency even when the level of I-Ek is reduced. The reduced level of CD4 affects selection of the 5C.C7 tg to a lesser degree than that of the AND tg.

We noted that the introduction of either TCR transgene (AND or 5C.C7) onto the CD4low mutant background results in thymi of greater cellularity, a phenomenon that is common in TCR tg mice when thymic selection is compromised. Several possibilities exist. 1) In the case of a relatively high affinity TCR (5C.C7), the selecting MHC may induce deletion as well. By reducing the level of CD4, i.e., weakening the TCR/MHC interaction, this deletion might be attenuated, resulting in increased cellularity. 2) The average lifespan of the DP thymocytes may be increased, resulting in increased cellularity. In the AND line, the cells undergoing selection may be receiving a signal through their TCR that is sufficient to protect them from PCD for a short time but insufficient to positively select them. Thus, they would "stall" in the DP stage for a time, resulting in increased cellularity. The DP stage is one of great expansion in the thymus. Removal of cells from this pool by positive selection could result in a decrease in overall cellularity. However, in a case of reduced positive selection (CD4low), the average lifespan of DP thymocytes may be lengthened because cells are not transitioning into the SP stage.

Other groups have shown that particular TCR V gene products are preferentially selected into either the CD4 or CD8 lineage (53, 54, 55, 56, 57). Here we show that a reduced level of CD4 influences the extent to which particular TCR V region gene products can be selected into the CD4 lineage (Table IIGo). Interestingly, for the panel of Abs we used with specificities for TCR V{alpha} or Vß domains, we found that four were significantly affected when CD4 was reduced on the C57BL/6 background, while only one was significantly affected in B10.BR mice. This supports the idea that specific TCR V regions are selected by MHC class (I or II) (55) as well as MHC allele.

In conclusion, our data support the idea that CD4 plays a crucial role in determining the avidity of the thymocyte-stromal cell interaction and whether the developing T cell has the avidity necessary to escape PCD. Further studies will be required to place quantitative limits on the window of avidity that exists for positive selection.


   Acknowledgments
 
The authors thank Dr. Mark Moore and Grace Cacalano for advice about the ES cell work and generation of the mutant mice; Dr. Christopher J. Wheeler for continued feedback, insight, and creative ideas; Dr. Michelle Tutt Landolfi for Abs and technical advice; Dr. Henry Neuman de Vegvar for computer assistance and technical advice; and Angela L. Lee for reagents and discussion.


   Footnotes
 
1 This work was supported by National Institutes of Health Grants CA46507 and AI19512. Back

2 Address correspondence and reprint requests to Dr. Jane R. Parnes, Department of Medicine, Division of Immunology and Rheumatology, Medical School Laboratory Surge Building P-306, Stanford University Medical Center, Stanford, CA 94305–5487. Back

3 Abbreviations used in this paper: DP, double-positive; PCD, programmed cell death; SP, single-positive; tg, transgene/transgenic; CD40, CD4 knockout; DN, double-negative; ES, embryonic stem; neo, neomycin resistance gene; UTR, untranslated region; low, low level; HSV, herpes simplex virus; tk, thymidine kinase; PGK, phosphoglycerate kinase-1; FIAU, 1-[2-deoxy-2-fluoro-ß-D-arabinofuranosyl]-5-iodouracil; ß2m0, ß2-microglobulin-deficient; PE, phycoerythrin; wt, wild-type; med, medium level; high, high level; PCC, pigeon cytochrome c. Back

Received for publication July 24, 1997. Accepted for publication September 30, 1997.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Parnes, J. R.. 1989. Molecular biology and function of CD4 and CD8. Adv. Immunol. 44:265.[Medline]
  2. Miceli, M. C., J. R. Parnes. 1993. Role of CD4 and CD8 in T cell activation and differentiation. Adv. Immunol. 53:59.[Medline]
  3. Teh, H. S., P. Kisielow, B. Scott, H. Kishi, Y. Uematsu, H. Bluthmann, H. von Boehmer. 1988. Thymic major histocompatibility complex antigens and the {alpha}ß T-cell receptor determine the CD4/CD8 phenotype of T cells. Nature 335:229.[Medline]
  4. Berg, L. J., A. M. Pullen, B. Fazekas de St. Groth, D. Mathis, C. Benoist, M. M. Davis. 1989. Antigen/MHC-specific T cells are preferentially exported from the thymus in the presence of their MHC ligand. Cell 58:1035.[Medline]
  5. Sha, W. C., C. A. Nelson, R. D. Newberry, D. M. Kranz, J. H. Russell, D. Y. Loh. 1988. Positive and negative selection of an antigen receptor on T cells in transgenic mice. Nature 336:73.[Medline]
  6. Kisielow, P., H. Bluthmann, U. D. Staerz, M. Steinmetz, H. von Boehmer. 1988. Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes. Nature 333:742.[Medline]
  7. Berg, L. J., G. D. Frank, M. M. Davis. 1990. The effects of MHC gene dosage and allelic variation on T cell receptor selection. Cell 60:1043.[Medline]
  8. Ashton-Rickardt, P. G., S. Tonegawa. 1994. A differential-avidity model for T-cell selection. Immunol. Today 15:362.[Medline]
  9. Lee, N. A., D. Y. Loh, E. Lacy. 1992. CD8 surface levels alter the fate of ab T cell receptor-expressing thymocytes in transgenic mice. J. Exp. Med. 175:1013.[Abstract/Free Full Text]
  10. Robey, E. A., F. Ramsdell, D. Kioussis, W. Sha, D. Loh, R. Axel, B. J. Fowlkes. 1992. The level of CD8 expression can determine the outcome of thymic selection. Cell 69:1089.[Medline]
  11. Ashton-Rickardt, P. G., A. Bandeira, J. R. Delaney, L. Van Kaer, H. P. Pircher, R. M. Zinkernagel, S. Tonegawa. 1994. Evidence for a differential avidity model of T cell selection in the thymus [see comments]. Cell 76:651.[Medline]
  12. Hogquist, K. A., S. C. Jameson, W. R. Heath, J. L. Howard, M. J. Bevan, F. R. Carbone. 1994. T cell receptor antagonist peptides induce positive selection. Cell 76:17.[Medline]
  13. Sebzda, E., V. A. Wallace, J. Mayer, R. S. Yeung, T. W. Mak, P. S. Ohashi. 1994. Positive and negative thymocyte selection induced by different concentrations of a single peptide. Science 263:1615.[Abstract/Free Full Text]
  14. Cammarota, G., A. Scheirle, B. Takacs, D. M. Doran, R. Knorr, W. Bannwarth, J. Guardiola, F. Sinigaglia. 1992. Identification of a CD4 binding site on the ß2 domain of HLA-DR molecules. Nature 356:799.[Medline]
  15. Konig, R., L. Y. Huang, R. N. Germain. 1992. MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8. Nature 356:796.[Medline]
  16. Emmrich, F.. 1988. Cross-linking of CD4 and CD8 with the T-cell receptor complex: quaternary complex formation and T-cell repertoire selection. Immunol. Today 9:296.[Medline]
  17. Jr Janeway, C. A.. 1988. T-cell development: accessories or coreceptors? [news]. Nature 335:208.[Medline]
  18. Abraham, N., M. C. Miceli, J. R. Parnes, A. Veillette. 1991. Enhancement of T-cell responsiveness by the lymphocyte-specific tyrosine protein kinase p56lck. Nature 350:62.[Medline]
  19. Veillette, A., M. A. Bookman, E. M. Horak, J. B. Bolen. 1988. The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck. Cell 55:301.[Medline]
  20. Ramsdell, F., B. J. Fowlkes. 1989. Engagement of CD4 and CD8 accessory molecules is required for T cell maturation. J. Immunol. 143:1467.[Abstract]
  21. Zuñiga-Pflucker, J. C., S. A. McCarthy, M. Weston, D. L. Longo, A. Singer, A. M. Kruisbeek. 1989. Role of CD4 in thymocyte selection and maturation. J. Exp. Med. 169:2085.[Abstract/Free Full Text]
  22. Killeen, N., D. R. Littman. 1993. Helper T-cell development in the absence of CD4-p56lck association. Nature 364:729.[Medline]
  23. Rahemtulla, A., T. M. Kundig, A. Narendran, M. F. Bachmann, M. Julius, C. J. Paige, P. S. Ohashi, R. M. Zinkernagel, T. W. Mak. 1994. Class II major histocompatibility complex-restricted T cell function in CD4-deficient mice. Eur. J. Immunol. 24:2213.[Medline]
  24. Locksley, R. M., S. L. Reiner, F. Hatam, D. R. Littman, N. Killeen. 1993. Helper T cells without CD4: control of leishmaniasis in CD4-deficient mice. Science 261:1448.[Abstract/Free Full Text]
  25. Smithies, O., R. G. Gregg, S. S. Boggs, M. A. Koralewski, R. S. Kucherlapati. 1985. Insertion of DNA sequences into the human chromosomal ß-globin locus by homologous recombination. Nature 317:230.[Medline]
  26. Thomas, K. R., M. R. Capecchi. 1987. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 51:503.[Medline]
  27. Field, E. H., B. Tourvieille, P. D’Eustachio, J. R. Parnes. 1987. The gene encoding the mouse T cell differentiation antigen L3T4 is located on chromosome 6. J. Immunol. 138:1968.[Abstract]
  28. McBurney, M. W., L. C. Sutherland, C. N. Adra, B. Leclair, M. A. Rudnicki, K. Jardine. 1991. The mouse pgk-1 gene promoter contains an upstream activator sequence. Nucleic Acids Res. 19:5755.[Abstract/Free Full Text]
  29. Sambrook, J., E. F. Fritsch, T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
  30. Gossler, A., T. Doetschman, R. Korn, E. Serfling, R. Kemler. 1986. Transgenesis by means of blastocyst-derived embryonic stem cell lines. Proc. Natl. Acad. Sci. USA 83:9065.[Abstract/Free Full Text]
  31. Bradley, A.. 1987. E. J. Robertson, ed. Teratocarcinomas and Embryonic Stem Cells: A Practical Approach IRL, Oxford.
  32. Kaye, J., M. L. Hsu, M. E. Sauron, S. C. Jameson, N. R. Gascoigne, S. M. Hedrick. 1989. Selective development of CD4+ T cells in transgenic mice expressing a class II MHC-restricted antigen receptor. Nature 341:746.[Medline]
  33. Greenberg, M. E.. 1995. Analysis of RNA by Northern and slot blot hybridization. F. M. Ausubel, and R. Brent, and R. E. Kingston, and D. D. Moore, and J. G. Seidman, and J. A. Smith, and K. Struhl, eds. Current Protocols in Molecular Biology, Vol. 1 4.9.1.-4.9.16. John Wiley and Sons, Inc, New York.
  34. Groettrup, M., K. Ungewiss, O. Azogui, R. Palacios, M. J. Owen, A. C. Hayday, H. von Boehmer. 1993. A novel disulfide-linked heterodimer on pre-T cells consists of the T cell receptor ß chain and a 33 kd glycoprotein. Cell 75:283.[Medline]
  35. Mansour, S. L., K. R. Thomas, M. R. Capecchi. 1988. Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature 336:348.[Medline]
  36. Sheets, M. D., S. C. Ogg, M. P. Wickens. 1990. Point mutations in AAUAAA and the poly (A) addition site: effects on the accuracy and efficiency of cleavage and polyadenylation in vitro. Nucleic Acids Res. 18:5799.[Abstract/Free Full Text]
  37. Fink, P. J., L. A. Matis, D. L. McElligott, M. Bookman, S. M. Hedrick. 1986. Correlations between T-cell specificity and the structure of the antigen receptor. Nature 321:219.[Medline]
  38. Kaye, J., N. J. Vasquez, S. M. Hedrick. 1992. Involvement of the same region of the T cell antigen receptor in thymic selection and foreign peptide recognition. J. Immunol. 148:3342.[Abstract]
  39. Guidos, C. J., I. L. Weissman, B. Adkins. 1989. Intrathymic maturation of murine T lymphocytes from CD8+ precursors. Proc. Natl. Acad. Sci. USA 86:7542.[Abstract/Free Full Text]
  40. Kisielow, P., W. Leiserson, H. Von Boehmer. 1984. Differentiation of thymocytes in fetal organ culture: analysis of phenotypic changes accompanying the appearance of cytolytic and interleukin 2-producing cells. J. Immunol. 133:1117.[Abstract]
  41. Jackson, R. J., N. Standart. 1990. Do the poly(A) tail and 3' untranslated region control mRNA translation?. Cell 62:15.[Medline]
  42. Sachs, A. B.. 1993. Messenger RNA degradation in eukaryotes. Cell 74:413.[Medline]
  43. Surh, C. D., J. Sprent. 1994. T-cell apoptosis detected in situ during positive and negative selection in the thymus [see comments]. Nature 372:100.[Medline]
  44. Robey, E. A., B. J. Fowlkes, J. W. Gordon, D. Kioussis, H. von Boehmer, F. Ramsdell, R. Axel. 1991. Thymic selection in CD8 transgenic mice supports an instructive model for commitment to a CD4 or CD8 lineage. Cell 64:99.[Medline]
  45. Lieberman, S. A., L. M. Spain, L. Wang, L. J. Berg. 1995. Enhanced T cell maturation and altered lineage commitment in T cell receptor/CD4-transgenic mice. Cell. Immunol. 162:56.[Medline]
  46. Davis, C. B., D. R. Littman. 1995. Disrupted development of thymocytes expressing a transgenic TCR upon CD4 overexpression. Int. Immunol. 7:1977.[Abstract/Free Full Text]
  47. Itano, A., D. Cado, F. K. Chan, E. Robey. 1994. A role for the cytoplasmic tail of the ß chain of CD8 in thymic selection. Immunity 1:287.[Medline]
  48. Crooks, M. E., D. R. Littman. 1994. Disruption of T lymphocyte positive and negative selection in mice lacking the CD8 ß chain. Immunity 1:277.[Medline]
  49. Hedrick, S. M., I. Engel, D. L. McElligott, P. J. Fink, M. L. Hsu, D. Hansburg, L. A. Matis. 1988. Selection of amino acid sequences in the ß chain of the T cell antigen receptor. Science 239:1541.[Abstract/Free Full Text]
  50. Yelon, D., L. J. Berg. 1997. Structurally similar TCRs differ in their efficiency of positive selection. J. Immunol. 158:5219.[Abstract]
  51. Hedrick, S. M., L. A. Matis, T. T. Hecht, L. E. Samelson, D. L. Longo, E. Heber-Katz, R. H. Schwartz. 1982. The fine specificity of antigen and Ia determinant recognition by T cell hybridoma clones specific for pigeon cytochrome c. Cell 30:141.[Medline]
  52. Matechak, E. O., N. Killeen, S. M. Hedrick, B. J. Fowlkes. 1996. MHC class II-specific T cells can develop in the CD8 lineage when CD4 is absent. Immunity 4:337.[Medline]
  53. Pircher, H., N. Reba, M. Groettrup, C. Grégoire, D. E. Speiser, M. P. Happ, E. Palmer, R. M. Zinkernagel, H. Hengartner, B. Malissen. 1992. Preferential positive selection of V{alpha}2+ CD8+ T cells in mouse strains expressing both H-2k and T cell receptor V{alpha} haplotypes: determination with a V{alpha}2-specific monoclonal antibody. Eur. J. Immunol. 22:399.[Medline]
  54. Jameson, S. C., J. Kaye, N. R. Gascoigne. 1990. A T cell receptor V {alpha} region selectively expressed in CD4+ cells. J. Immunol. 145:1324.[Abstract]
  55. Sim, B. C., L. Zerva, M. I. Greene, N. R. J. Gascoigne. 1996. Control of MHC restriction by TCR V{alpha} CDR1 and CDR2. Science 273:963.[Abstract]
  56. Utsunomiya, Y., J. Bill, E. Palmer, K. Gollob, Y. Takagaki, O. Kanagawa. 1989. Analysis of a monoclonal rat antibody directed to the {alpha}-chain variable region (V{alpha}3) of the mouse T cell antigen receptor. J. Immunol. 143:2602.[Abstract]
  57. Liao, N. S., J. Maltzman, D. H. Raulet. 1989. Positive selection determines T cell receptor Vß14 gene usage by CD8+ T cells. J. Exp. Med. 170:135.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 J. Immunol.Home page
O. Boyer, G. Marodon, J. L. Cohen, L. Lejeune, T. Irinopoulou, R. Liblau, P. Bruneval, and D. Klatzmann
Human CD4 Expression at the Late Single-Positive Stage of Thymic Development Supports T Cell Maturation and Peripheral Export in CD4-Deficient Mice
J. Immunol., October 15, 2002; 169(8): 4347 - 4353.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
N. G. Singer, D. A. Fox, T. M. Haqqi, L. Beretta, J. S. Endres, S. Prohaska, J. R. Parnes, J. Bromberg, and R. M. Sramkoski
CD6: expression during development, apoptosis and selection of human and mouse thymocytes
Int. Immunol., June 1, 2002; 14(6): 585 - 597.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
G. J. Wiegers, I. E. M. Stec, W. E. F. Klinkert, and J. M. H. M. Reul
Glucocorticoids Regulate TCR-Induced Elevation of CD4: Functional Implications
J. Immunol., June 15, 2000; 164(12): 6213 - 6220.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. A. Mostaghel, J. M. Riberdy, D. A. Steeber, and C. Doyle
Coreceptor-Independent T Cell Activation in Mice Expressing MHC Class II Molecules Mutated in the CD4 Binding Domain
J. Immunol., December 15, 1998; 161(12): 6559 - 6566.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frank, G. D.
Right arrow Articles by Parnes, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frank, G. D.
Right arrow Articles by Parnes, J. R.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS